Articles

The article explores the increasing impact of medical negligence claims on the UK’s healthcare and pharmaceutical sectors, highlighting the need for robust risk management. Key points include: Rise in Claims Pharmaceutical Accountability Clinical Trial Risks Post-Pandemic Challenges Cultural Shift Statistics and Costs
Clinical errors are not just unfortunate events for the individuals affected, they have far-reaching consequences for the UK healthcare system and the wider pharmaceutical industry. As medical innovation accelerates and clinical trials expand across borders, the ripple effects of medical negligence are increasingly evident. For pharmaceutical companies, clinical research organisations (CROs), and NHS partners, effective risk management is no longer optional, it is esse…

The eClinical solutions market encompasses a broad range of digital tools and software designed to support clinical trial management and execution. These platforms integrate various functions such as trial planning, data collection, patient monitoring, regulatory compliance, and outcome tracking. In recent years, stakeholders across the healthcare and life sciences sectors have recognized the transformative potential of eClinical technologies in accelerating research timelines and enhancing data quality.
Overview of the eClinical Solutions Market Landscape The eClinical solutions market encompasses a broad range of digital tools and software designed to support clinical trial management and execution. These platforms integrate various functions such as trial planning, data collection, patie…

The global mesenchymal stem cells market is witnessing a significant transformation as advancements in regenerative medicine and personalized therapies continue to reshape the healthcare landscape. According to the latest market report by Acumen Research and Consulting, the global mesenchymal stem cells market size accounted for USD 3.16 billion in 2023 and is anticipated to reach USD 9.17 billion by 2032. This represents a robust compound annual growth rate of 12.7 percent from 2024 to 2032.
Introduction The global mesenchymal stem cells market is witnessing a significant transformation as advancements in regenerative medicine and personalized therapies continue to reshape the healthcare landscape. According to the latest market report by Acumen Research and Consulting, the global mesenchy…

Patient payment processes in pharma can be disjointed and overly complex. Pharmaceutical leaders can improve the process by offering real-time benefit verification tools, enabling omnichannel payment options, automating communication and reminders, and more.
Patient payment processes in pharma can be disjointed and overly complex. This can cause higher therapy abandonment rates and unnecessary delays in treatment. Rising out-of-pocket costs only add to the burden, making it harder for individuals to start or stay on prescribed medications. Pharma companies that fail to address these friction points risk losing trust, revenue and long-term adherence. Brands must streamline how payments are verified and completed, turning complicated experiences into clear journeys to stay competitive and pat…

The Global Electronic Health Records Market Size was valued at USD 31.7 Billion in 2023 and is anticipated to reach USD 51.2 Billion by 2032 with a CAGR of 5.6% from 2024 to 2032.
Market Overview The electronic health records market encompasses software solutions used to collect, store, and manage patient health information in digital format. These platforms enable the electronic sharing of medical information between different healthcare stakeholders, including physicians, nurses, laboratories, pharmacies, and payers. EHR systems include various modules such as clinical documentation, computerized physician order entry, e-prescription, clinical decision support, billing, and analytics. The global EHR market is witnessing robust growth fueled by increased healthcare spending, widespread dig…

Bone marrow transplantation market, also referred to as hematopoietic stem cell transplantation, is a medical procedure aimed at replacing damaged or destroyed bone marrow with healthy stem cells. It plays a pivotal role in treating various types of blood cancers and non-malignant conditions like aplastic anemia and sickle cell disease. Over the past decade
Overview of the Bone Marrow Transplantation Market Bone marrow transplantation market, also referred to as hematopoietic stem cell transplantation, is a medical procedure aimed at replacing damaged or destroyed bone marrow with healthy stem cells. It plays a pivotal role in treating various types of blood cancers and non-malignant conditions like aplastic anemia and sickle cell disease. Over the past decade, this treatment modality has e…

Biocatalysis employs biological systems, particularly enzymes, to catalyse chemical reactions. These natural catalysts facilitate chemical transformations on organic compounds, providing significant advantages over traditional methods.
Biocatalysis employs biological systems, particularly enzymes, to catalyse chemical reactions. These natural catalysts facilitate chemical transformations on organic compounds, providing significant advantages over traditional methods. Challenges with Traditional Catalytic Systems Traditional catalysts, based on inorganic and organic molecules, are essential in synthesizing complex molecules but face several challenges: Cost: Catalysts can be very expensive to purchase. Maintenance: They often need to be removed from a product and cleaned. Specificity:…

The field of protein production is seeing widespread adoption of cell-free protein synthesis (CFPS), revolutionising the industry with its high-throughput and cost-effective capabilities. This innovative method has created new opportunities for synthesising proteins, especially those that are challenging to produce in living cells. But what makes cell-free protein synthesis so advantageous, and why is it the preferred choice for high-throughput screening and directed evolution?
The Benefits of Cell-Free Protein Synthesis in Protein Production The field of protein production is seeing widespread adoption of cell-free protein synthesis (CFPS), revolutionising the industry with its high-throughput and cost-effective capabilities. This innovative method has created new opportunities f…

Medical cannabis is gaining recognition as an effective treatment for a range of health conditions, especially when standard therapies fall short. In the UK, clinics such as MARUCANNA are leading the way in prescribing cannabis-based medications, focusing on personalised care to enhance patients’ wellbeing. Here are five common conditions where medical cannabis is making a meaningful difference: chronic pain, epilepsy, palliative care, anxiety, and Crohn’s disease.
Medical cannabis has emerged as a promising treatment option for various health conditions, particularly where conventional therapies have proven inadequate. In the UK, clinics like MARUCANNA are at the forefront of prescribing cannabis-based medicines, offering personalised care to improve patients’ quality of life. Below, we ex…

The High Potent Active Pharmaceutical Ingredient (HPAPI) Market is undergoing a transformative phase, driven by the increasing demand for precision medicine and targeted therapies. In 2023, the market was valued at USD 26.8 Billion, and it is projected to grow at an impressive CAGR of 8.9%, reaching USD 57.6 Billion by 2032. This rapid expansion is fueled by advancements in oncology treatments, the rise of biologics, and the growing need for highly effective, low-dose medications.
The High Potent Active Pharmaceutical Ingredient (HPAPI) Market is undergoing a transformative phase, driven by the increasing demand for precision medicine and targeted therapies. In 2023, the market was valued at USD 26.8 Billion, and it is projected to grow at an impressive CAGR of 8.9%, rea…

The Hypertension Drugs Market, a critical segment of the global pharmaceutical industry, continues to expand as the prevalence of high blood pressure rises worldwide. In 2023, the market was valued at USD 26.5 Billion, and it is projected to grow at a CAGR of 4.2%, reaching USD 38.3 Billion by 2032. This growth is fueled by increasing hypertension cases, aging populations, and advancements in drug development.
 Market overview: The Hypertension Drugs Market, a critical segment of the global pharmaceutical industry, continues to expand as the prevalence of high blood pressure rises worldwide. In 2023, the market was valued at USD 26.5 Billion, and it is projected to grow at a CAGR of 4.2%, reaching USD 38.3 Billion by 2032. This growth is fueled by increasing hypert…

The global vaccines market has witnessed unprecedented growth in recent years, driven by technological advancements, rising disease prevalence, and increased government initiatives.
          Introduction The global vaccines market has witnessed unprecedented growth in recent years, driven by technological advancements, rising disease prevalence, and increased government initiatives. Vaccines play a critical role in preventing infectious diseases, reducing healthcare costs, and improving public health outcomes. With the COVID-19 pandemic accelerating vaccine development and distribution, the industry is evolving rapidly. This article explores the current state of the vaccines market, key trends, challenges, and future opportunities. Market Overview The vaccines mar…

Gestational diabetes (GD) is a condition that occurs during pregnancy, where a woman without diabetes develops high blood sugar levels. The condition typically appears in the second or third trimester and often resolves after childbirth. However, women who experience gestational diabetes are at an increased risk of developing Type 2 diabetes later in life.
Introduction Gestational diabetes (GD) is a condition that occurs during pregnancy, where a woman without diabetes develops high blood sugar levels. The condition typically appears in the second or third trimester and often resolves after childbirth. However, women who experience gestational diabetes are at an increased risk of developing Type 2 diabetes later in life. The market for gestational diabetes is growing due to increasing aware…

Intravenous (IV) solutions are sterile fluids, injected into a person's veins through an IV (intravenous) tube. It is intended for use in patient care. They are used to prevent or treat dehydration, electrolyte imbalances, nutrient deficiency, and others. IV solutions are primarily preferred for individuals especially those who are sick, injured, and dehydrated.
Intravenous Solution Market Size: Intravenous Solution Market size is estimated to reach over USD 24,667.69 Million by 2031 from a value of USD 12,443.55 Million in 2023, growing at a CAGR of 9.1% from 2024 to 2031. Intravenous Solution Market Overview: The Intravenous (IV) Solution Market encompasses the production and distribution of sterile solutions administered directly into a patient's vein. These solutions are critical for ma…

The cochlear implants are medical devices designed to provide hearing to individuals with severe to profound sensorineural hearing loss. Cochlear implants bypass damaged parts of the inner ear by directly stimulating the auditory nerve, enabling sound perception. These devices consist of external components, such as microphones and speech processors, and surgically implanted internal components, including electrodes and a receiver-stimulator.
Cochlear Implant Market Size: Cochlear Implant Market size is estimated to reach over USD 3,175.45 Million by 2032 from a value of USD 1,780.55 Million in 2024 and is projected to grow by USD 1,882.36 Million in 2025, growing at a CAGR of 7.5% from 2025 to 2032.   Cochlear Implant Market Analysis Overview: The global cochlear implant market is exp…

The growing incidence of strokes globally, particularly ischemic strokes, has compelled healthcare systems to adopt modern endovascular techniques. Blood clot retrieval devices offer immediate restoration of blood flow to the brain, significantly reducing the chances of disability or death. The increasing availability of trained neurosurgeons and interventional radiologists has further contributed to the widespread adoption of these devices.
Market Overview The global healthcare ecosystem is undergoing rapid transformation due to the increasing prevalence of chronic diseases and demand for minimally invasive therapies. The blood clot retrieval devices market stands at the intersection of these shifts. These devices are vital in removing clots from the brain’s arteries in patients suffering…

Electrophoresis is a core analytical technique widely used across biotechnology pharmaceutical academic and clinical research environments. It facilitates the separation identification and analysis of macromolecules such as DNA RNA and proteins which are vital in the study of genetic diseases drug development and molecular biology.
What is Electrophoresis and Why is it Crucial in Modern Research Electrophoresis Market refers to the movement of charged particles under the influence of an electric field. This technique has become an essential laboratory method for separating complex mixtures of biological molecules. Researchers and scientists depend heavily on this method in fields such as genomics proteomics forensic science and diagnostic laboratories. Its flexibility cost effectiveness and…

Today, Molecular Devices launched the QPix® FLEX™ Microbial Colony Picking System that picks, plates and analyzes microbial colonies with over 95% efficiency and nearly 100% accuracy. The benchtop platform automates end-to-end microbiology workflows and boosts productivity with advanced multimodal imaging and high-efficiency picking. When done manually, microbial colony picking creates workflow bottlenecks and risks contamination and tracking errors. QPix FLEX Microbial Colony Picking System overcomes these barriers with its: • Precision Picking with Phenotypic Insight • Built-In Sterility and Traceability • End-to-End Workflow Automation
Molecular Devices, LLC., a leading high-performance life science solutions provider, today launched the QPix® FLEX™ Microbial Colony Picking Sys…

Quality Assurance (QA) means putting a formal system in place with the help of plans, policies, and procedures to ensure that products are manufactured and tested accurately in compliance with relevant standards. Quality Control is a set of procedures and activities that ensures the quality, safety, and efficacy of products by sampling, testing analyzing raw materials, in-process samples, and finished products during different stages of production.
In the pharmaceutical and life sciences industries, the terms Quality Assurance (QA) and Quality Control (QC) are often used interchangeably, but they represent two distinct and critical functions within a Quality Management System (QMS). Misunderstanding the difference between QA and QC can lead to inefficiencies, complian…

According to a new global survey by Johnson & Johnson MedTech, a growing number of Europeans are embracing the potential of technology to reshape the arc of care. The findings — spanning 11 countries and hundreds of voices — suggest that trust in digital solutions is no longer confined to experts, but shared by everyone and anchored in the real, human hope of better health.
A new global survey conducted by Johnson & Johnson MedTech reveals strong public and professional support across Europe for the use of data and technology to drive more personalized and effective healthcare delivery. The survey, which included respondents from France, Germany, Italy, and the UK, found that 73% of European adults are willing to share their health data in exchange for personalized treatment plans — a f…